OptiNose, Inc. - Common Stock (OPTN)

Optinose Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapeutic solutions for patients suffering from sinus and allergy-related conditions

The company's primary product utilizes its proprietary drug delivery technology to administer medications directly to the nasal cavity, aimed at improving the treatment efficacy for various disorders, including chronic rhinosinusitis and allergic rhinitis. Through its commitment to research and development, Optinose strives to enhance patient outcomes and quality of life by delivering effective, non-invasive treatment options.